Skip to main content
. 2021 Feb 24;40(1):21–27. doi: 10.1089/mab.2020.0033

FIG. 3.

FIG. 3.

In vivo efficacy of JMAM-1 mAb in the NCI-H226 CDX model BALB/c nude mice were injected S.C. with NCI-H226 cells. After 3 weeks, 10 and 100 μg/mL JMAM-1 mAb and control PBS, respectively, were administered intraperitoneally from days 1 to 23, every 2 or 3 days for 11 times. PBS, phosphate-buffered saline.